All Stories

  1. Dose response of umeclidinium administered once or twice daily in patients with COPD: A pooled analysis of two randomized, double-blind, placebo-controlled studies
  2. Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease